- Home
- BBCP vs GNFT Comparison
BBCP vs GNFT Comparison
Compare BBCP & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBCP
- GNFT
- Stock Information
- Founded
- BBCP 1983
- GNFT 1999
- Country
- BBCP United States
- GNFT France
- Employees
- BBCP N/A
- GNFT N/A
- Industry
- BBCP Engineering & Construction
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BBCP Consumer Discretionary
- GNFT Health Care
- Exchange
- BBCP Nasdaq
- GNFT Nasdaq
- Market Cap
- BBCP 370.5M
- GNFT 190.6M
- IPO Year
- BBCP 2017
- GNFT 2019
- Fundamental
- Price
- BBCP $6.70
- GNFT $3.71
- Analyst Decision
- BBCP Buy
- GNFT Strong Buy
- Analyst Count
- BBCP 4
- GNFT 1
- Target Price
- BBCP $7.67
- GNFT $13.00
- AVG Volume (30 Days)
- BBCP 83.0K
- GNFT 7.9K
- Earning Date
- BBCP 01-09-2025
- GNFT 09-19-2024
- Dividend Yield
- BBCP N/A
- GNFT N/A
- EPS Growth
- BBCP N/A
- GNFT N/A
- EPS
- BBCP 0.26
- GNFT 0.47
- Revenue
- BBCP $434,594,000.00
- GNFT $86,225,222.00
- Revenue This Year
- BBCP N/A
- GNFT $155.44
- Revenue Next Year
- BBCP N/A
- GNFT N/A
- P/E Ratio
- BBCP $25.47
- GNFT $7.55
- Revenue Growth
- BBCP N/A
- GNFT 175.45
- 52 Week Low
- BBCP $5.05
- GNFT $3.31
- 52 Week High
- BBCP $8.48
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- BBCP 50.96
- GNFT 33.06
- Support Level
- BBCP $6.39
- GNFT $3.63
- Resistance Level
- BBCP $6.74
- GNFT $3.94
- Average True Range (ATR)
- BBCP 0.26
- GNFT 0.13
- MACD
- BBCP -0.11
- GNFT 0.03
- Stochastic Oscillator
- BBCP 29.52
- GNFT 19.17
About BBCP Concrete Pumping Holdings Inc.
Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators position it to deliver concrete placement solutions. The company's operating segment includes U.S. Concrete Pumping; U.K. Operations; U.S. Concrete Waste Management Services and Corporate. It generates maximum revenue from the U.S. Concrete Pumping segment. Geographically, it generates majority of the revenue from its business in United States.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.